Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Revision Hip and Knee Arthroplasty as Reported by American Board of Orthopaedic Surgery Part II Candidates

Warren, 2019, Venous thromboembolism rates did not decrease in lower extremity revision total joint arthroplasty from 2008 to 2016, J Arthroplasty, 34, 2774, 10.1016/j.arth.2019.05.012 Freedman, 2000, A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty, J Bone Joint Surg Am, 82-A, 929, 10.2106/00004623-200007000-00004 Migita, 2014, Venous thromboembolism after total joint arthroplasty: results from a Japanese multicenter cohort study, Arthritis Res Ther, 16, R154, 10.1186/ar4616 Sarmiento, 2005, Thromboembolic disease prophylaxis in total hip arthroplasty, Clin Orthop Relat Res, 436, 138, 10.1097/01.blo.0000161824.52515.31 Hamilton, 2015, Mechanical thromboembolic prophylaxis with risk stratification in total knee arthroplasty, J Arthroplasty, 30, 43, 10.1016/j.arth.2014.08.006 Bin Abd Razak, 2012, Incidence of clinically significant venous thromboembolic events in Asian patients undergoing total knee arthroplasty without anticoagulation, J Arthroplasty, 27, 1128, 10.1016/j.arth.2011.09.024 Khatod, 2012, Pulmonary embolism prophylaxis in more than 30,000 total knee arthroplasty patients: is there a best choice?, J Arthroplasty, 27, 167, 10.1016/j.arth.2011.04.006 Khatod, 2011, Prophylaxis against pulmonary embolism in patients undergoing total hip arthroplasty, J Bone Joint Surg Am, 93, 1767, 10.2106/JBJS.J.01130 Parvizi, 2014, Symptomatic pulmonary embolus after joint arthroplasty: stratification of risk factors, Clin Orthop Relat Res, 472, 903, 10.1007/s11999-013-3358-z Allen, 2015, CT pulmonary angiography and pulmonary embolism following 5809 primary joint arthroplasties, N Z Med J, 128, 41 Shahi, 2017, The incidence and economic burden of in-hospital venous thromboembolism in the United States, J Arthroplasty, 32, 1063, 10.1016/j.arth.2016.10.020 Ast, 2014, Clinical outcomes of patients with non-fatal VTE after total knee arthroplasty, J Arthroplasty, 29, 37, 10.1016/j.arth.2013.04.013 Cusick, 2009, The incidence of fatal pulmonary embolism after primary hip and knee replacement in a consecutive series of 4253 patients, J Bone Joint Surg Br, 91, 645, 10.1302/0301-620X.91B5.21939 Runner, 2019, Utilization patterns, efficacy, and complications of venous thromboembolism prophylaxis strategies in primary hip and knee arthroplasty as reported by American Board of Orthopedic Surgery Part II candidates, J Arthroplasty, 34, 729, 10.1016/j.arth.2018.12.015 Bautista, 2019, Thromboprophylaxis for hip revision arthroplasty: can we use the recommendations for primary hip surgery? A cohort study, Clin Appl Thromb Hemost, 25, 10.1177/1076029618820167 Weber, 2012, Superior labrum anterior and posterior lesions of the shoulder: incidence rates, complications, and outcomes as reported by American Board of Orthopedic Surgery. Part II candidates, Am J Sports Med, 40, 1538, 10.1177/0363546512447785 Gottschalk, 2016, Humeral shaft fracture fixation: incidence rates and complications as reported by American Board of Orthopaedic Surgery Part II candidates, J Bone Joint Surg Am, 98, e71, 10.2106/JBJS.15.01049 Lieberman, 2017, Pulmonary embolism rates following total hip arthroplasty with prophylactic anticoagulation: some pulmonary emboli cannot be avoided, J Arthroplasty, 32, 980, 10.1016/j.arth.2016.09.006 Lieberman, 2013, Prevention of venous thromboembolic disease after total hip and knee arthroplasty, J Bone Joint Surg Am, 95, 1801, 10.2106/JBJS.L.01328 An, 2016, Aspirin as thromboprophylaxis in hip and knee arthroplasty: a systematic review and meta-analysis, J Arthroplasty, 31, 2608, 10.1016/j.arth.2016.04.004 Jameson, 2012, The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after knee replacement: a non-randomised comparison using National Joint Registry Data, J Bone Joint Surg Br, 94, 914, 10.1302/0301-620X.94B7.29129 Jameson, 2011, The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after hip replacement: a non-randomised comparison from information in the National Joint Registry, J Bone Joint Surg Br, 93, 1465, 10.1302/0301-620X.93B11.27622 Bohl, 2016, How much do adverse event rates differ between primary and revision total joint arthroplasty?, J Arthroplasty, 31, 596, 10.1016/j.arth.2015.09.033 Kurtz, 2007, Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030, J Bone Joint Surg Am, 89, 780, 10.2106/00004623-200704000-00012 Schwartz, 2020, Projections and epidemiology of revision hip and knee arthroplasty in the United States to 2030, J Arthroplasty, 10.1016/j.arth.2020.02.030 Schwartz, 2016, Revision total hip arthroplasty in the United States: national trends and in-hospital outcomes, Int Orthop, 40, 1793, 10.1007/s00264-016-3121-7 Rajaee, 2018, Increasing burden of total hip arthroplasty revisions in patients between 45 and 64 years of age, J Bone Joint Surg Am, 100, 449, 10.2106/JBJS.17.00470 Odeh, 2016, Risk-stratified venous thromboembolism prophylaxis after total joint arthroplasty: aspirin and sequential pneumatic compression devices vs aggressive chemoprophylaxis, J Arthroplasty, 31, 78, 10.1016/j.arth.2016.01.065 Nam, 2016, The effectiveness of a risk stratification protocol for thromboembolism prophylaxis after hip and knee arthroplasty, J Arthroplasty, 31, 1299, 10.1016/j.arth.2015.12.007 Nam, 2015, Thromboembolism prophylaxis in hip arthroplasty: routine and high risk patients, J Arthroplasty, 30, 2299, 10.1016/j.arth.2015.06.045 Boylan, 2017, Venous thromboembolic disease in revision vs primary total knee arthroplasty, J Arthroplasty, 32, 1996, 10.1016/j.arth.2016.12.051 Huang, 2016, Aspirin is as effective as and safer than warfarin for patients at higher risk of venous thromboembolism undergoing total joint arthroplasty, J Arthroplasty, 31, 83, 10.1016/j.arth.2016.02.074 Tan, 2019, Potent anticoagulation does not reduce venous thromboembolism in high-risk patients, J Bone Joint Surg Am, 101, 589, 10.2106/JBJS.18.00335 Courtney, 2017, Are revision hip arthroplasty patients at higher risk for venous thromboembolic events than primary hip arthroplasty patients?, J Arthroplasty, 32, 3752, 10.1016/j.arth.2017.07.028 Tang, 2020, Low-dose aspirin is safe and effective for venous thromboembolism prevention in patients undergoing revision total hip arthroplasty: a retrospective cohort study, J Arthroplasty, 10.1016/j.arth.2020.03.040 Deirmengian, 2016, Aspirin can be used as prophylaxis for prevention of venous thromboembolism after revision hip and knee arthroplasty, J Arthroplasty, 31, 2237, 10.1016/j.arth.2016.03.031 Huang, 2015, Administration of aspirin as a prophylaxis agent against venous thromboembolism results in lower incidence of periprosthetic joint infection, J Arthroplasty, 30, 39, 10.1016/j.arth.2015.07.001 Gutowski, 2015, Direct costs of aspirin versus warfarin for venous thromboembolism prophylaxis after total knee or hip arthroplasty, J Arthroplasty, 30, 36, 10.1016/j.arth.2015.04.048 Schousboe, 2013, Cost-effectiveness of low-molecular-weight heparin compared with aspirin for prophylaxis against venous thromboembolism after total joint arthroplasty, J Bone Joint Surg Am, 95, 1256, 10.2106/JBJS.L.00400 Parvizi, 2017, Low-dose aspirin is effective chemoprophylaxis against clinically important venous thromboembolism following total joint arthroplasty: a preliminary analysis, J Bone Joint Surg Am, 99, 91, 10.2106/JBJS.16.00147 Feldstein, 2017, A comparison of two dosing regimens of ASA following total hip and knee arthroplasties, J Arthroplasty, 10.1016/j.arth.2017.01.009